Trademark: 88618601
Word
ELEVAR
Status
Pending
Status Code
734
Status Date
Monday, December 11, 2023
Serial Number
88618601
Mark Type
3000
Filing Date
Monday, September 16, 2019
Published for Opposition
Tuesday, April 13, 2021

Trademark Owner History
Elevar Therapeutics, Inc. - Owner At Publication

Classifications
5 Novel cancer therapies, namely, pharmaceutical preparations and substances for the treatment of cancer
35 Information services, namely, providing consumer product information for medical professionals in the field of cancer and cancer treatment via a global computer network
42 Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments
The mark consists of the stylized blue lowercase wording "ELEVAR". Above the letters "A" and "R" is the stylized design of wings in the gradient colors of blue, light blue and dark blue depicting a bird.
The color(s) blue, light blue and dark blue is/are claimed as a feature of the mark.
The English translation of the word "ELEVAR" in the mark is "to raise".

Trademark Events
Dec 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2023
Sou Extension 5 Granted
Dec 5, 2023
Sou Extension 5 Filed
Dec 5, 2023
Sou Teas Extension Received
Jun 10, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 8, 2023
Sou Extension 4 Granted
Jun 8, 2023
Sou Extension 4 Filed
Jun 8, 2023
Sou Teas Extension Received
Jun 7, 2023
Teas Change Of Correspondence Received
Jun 7, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 7, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 10, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2022
Sou Extension 3 Granted
Dec 8, 2022
Sou Extension 3 Filed
Dec 8, 2022
Sou Teas Extension Received
Jun 17, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2022
Sou Extension 2 Granted
Jun 8, 2022
Sou Extension 2 Filed
Jun 15, 2022
Case Assigned To Intent To Use Paralegal
Jun 8, 2022
Sou Teas Extension Received
Jun 8, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 8, 2022
Teas Change Of Correspondence Received
Jun 8, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 8, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 8, 2022
Teas Change Of Owner Address Received
Dec 10, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 8, 2021
Sou Extension 1 Granted
Dec 8, 2021
Sou Extension 1 Filed
Dec 8, 2021
Sou Teas Extension Received
Aug 23, 2021
Exparte Appeal Terminated
Jun 8, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 13, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 13, 2021
Published For Opposition
Mar 24, 2021
Notification Of Notice Of Publication E-Mailed
Mar 10, 2021
Approved For Pub - Principal Register
Feb 10, 2021
Teas/Email Correspondence Entered
Feb 9, 2021
Correspondence Received In Law Office
Feb 9, 2021
Teas Response To Office Action Received
Jan 19, 2021
Notification Of Non-Final Action E-Mailed
Jan 19, 2021
Non-Final Action E-Mailed
Jan 19, 2021
Non-Final Action Written
Dec 18, 2020
Teas/Email Correspondence Entered
Dec 18, 2020
Correspondence Received In Law Office
Dec 16, 2020
Teas Request For Reconsideration Received
Dec 17, 2020
Ex Parte Appeal-Instituted
Dec 17, 2020
Jurisdiction Restored To Examining Attorney
Dec 17, 2020
Exparte Appeal Received At Ttab
Jun 16, 2020
Notification Of Final Refusal Emailed
Jun 16, 2020
Final Refusal E-Mailed
Jun 16, 2020
Final Refusal Written
May 21, 2020
Teas/Email Correspondence Entered
May 21, 2020
Correspondence Received In Law Office
May 21, 2020
Assigned To Lie
May 15, 2020
Teas Response To Office Action Received
Nov 15, 2019
Notification Of Non-Final Action E-Mailed
Nov 15, 2019
Non-Final Action E-Mailed
Nov 15, 2019
Non-Final Action Written
Nov 12, 2019
Assigned To Examiner
Sep 26, 2019
Notice Of Design Search Code E-Mailed
Sep 25, 2019
New Application Office Supplied Data Entered
Sep 19, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24